December 17, 2020 Update:
A proposed Canada-wide settlement has been reached in the Canadian Actos/Pioglitazone class actions.
Public hearings to determine if the proposed settlement will be approved by the Courts will take place on January 27 and 28, 2021.
For more details, please read the below Notice (in PDF) or visit the Settlement Administration website at www.piosettlement.ca
You can also contact Merchant Law Group LLP at 1-866-982-7777 or email us at firstname.lastname@example.org with your full contact information, and our law firm will call you to arrange for a confidential consultation with one of our Actos lawyers. There is no fee for this consultation.
January 15, 2019 Update:
Actos Class Action Lawsuit
Actos is an anti-diabetic drug prescribed to decrease blood sugar levels in patients with type 2 diabetes.
Actos Increases the Risk of Bladder Cancer
In 2012, Health Canada issued a warning that the use of Actos may be linked to bladder cancer. A ten-year observational study found that there may be a 40 percent increased risk of bladder cancer for people who have taken Actos for more than one year.
Are You Eligible for Compensation?
If you have taken Actos for more than one year to manage your type 2 diabetes and have since developed bladder cancer, you may be eligable for compensation, if this class action is successful. Compensation might also be available for the family and estate of a deceased person who used Actos and experienced bladder cancer.
If you wish to be kept advised of the status of the Actos class action and any resulting compensation program resulting from this litigation in Canada, please provide your contact information to our law firm using the below form. Or email email@example.com with your full contact information, and our law firm will call you to arrange for a confidential consultation with one of our Actos lawyers. There is no fee for this consultation.
Other details about the Actos Class Action Lawsuit
Actos was approved for sale in Canada in 2000 to control blood sugar levels in people with Type 2 diabetes.
A 2011 treatment study reported to the FDA a clear link between Actos and increased bladder cancer risk. Health Canada subsequently commenced a year-long review and, in April 2012, following that review, the product monographs of ACTOS were updated to reflect the increased risk of bladder cancer.
The Start and Spread Of Bladder Cancer
Most bladder cancers start in the inner lining of the bladder, as the cancer grows into or through the other layers in the bladder wall, it becomes more advanced and can be harder to treat and eventually spreading to nearby lymph nodes or other parts of the body.
Symptoms and Signs
Blood in the urine (called hematuria) is commonly the first sign of bladder cancer. Sometimes, there is enough blood to change the color of the urine to orange, pink, or, less often, darker red. Ask a doctor for a urinalysis if you happen to have blood in your urine. Blood can appear with a person without bladder cancer however if blood reappears you have a HIGH risk of having bladder cancer.
Bladder cancer also causes changes in urination such as:
- Having to urinate more frequently
- Pain or burning sensation while urinating
- Feeling the urge to go when bladder isn’t full
- Having troubles urinating or a weak urine stream
Merchant Law Group LLP has twelve offices across Canada.